Activity in this selectionJul 31, 2026 · Jul 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $815M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionK2 SpaceManufactures large, high-power satellites.
Role not disclosedAdvanCellAdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.
Role not disclosed